Sarepta Therapeutics, Inc. (SRPT)

Sarepta Therapeutics Market Cap

Sarepta Therapeutics has a market cap or net worth of $6.32 billion as of March 31, 2025. Its market cap has decreased by -44.77% in one year.

• Market Cap: 6.32B
• Enterprise Value: 6.82B
• 1-Year Change: -44.77%
• Ranking: #1077
• Category: Mid-Cap
• Stock Price: $65.15

Market Cap Chart

Since December 1, 1998, Sarepta Therapeutics's market cap has increased from $58.40M to $6.32B, an increase of 10,724.73%. That is a compound annual growth rate of 19.46%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	6.83B	-41.18%
Dec 31, 2024	11.61B	28.75%
Dec 29, 2023	9.02B	-20.70%
Dec 30, 2022	11.37B	45.06%
Dec 31, 2021	7.84B	-41.72%
Dec 31, 2020	13.45B	39.87%
Dec 31, 2019	9.62B	31.90%
Dec 31, 2018	7.29B	102.79%
Dec 29, 2017	3.60B	140.16%
Dec 30, 2016	1.50B	-14.27%
Dec 31, 2015	1.75B	192.17%
Dec 31, 2014	597.80M	-21.92%
Dec 31, 2013	765.60M	16.58%
Dec 31, 2012	656.70M	549.55%
Dec 30, 2011	101.10M	-57.54%
Dec 31, 2010	238.10M	47.70%
Dec 31, 2009	161.20M	244.44%
Dec 31, 2008	46.80M	-38.26%
Dec 31, 2007	75.80M	-54.99%
Dec 29, 2006	168.40M	10.50%
Dec 30, 2005	152.40M	79.51%
Dec 31, 2004	84.90M	-33.15%
Dec 31, 2003	127.00M	-3.93%
Dec 31, 2002	132.20M	-47.73%
Dec 31, 2001	252.90M	148.18%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	723.95B
UnitedHealth Group	474.90B
Johnson & Johnson	396.18B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	226.38B